Day One Biopharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
DAWN Nasdaq 8731 https://dayonebio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Day One Biopharmaceuticals Inc

At What Oil Price Will Shale Drillers Stop Drilling? - Oct 2nd, 2024 12:00 am
Taylor Fritz’s Girlfriend Morgan Riddle Opts for Classic Little Black Dress on Day One of the U.S. Open 2024 - Aug 27th, 2024 4:49 pm
Jeff Bezos Said 'I Predict One Day Amazon Will Fail' And Claims Large Companies Only Last '30-Plus Years' – Guess How Old Amazon Is? - Aug 19th, 2024 3:15 pm
A great week that adds to Day One Biopharmaceuticals, Inc.'s (NASDAQ:DAWN) one-year returns, institutional investors who own 56% must be happy - Aug 16th, 2024 11:39 am
Bank of America Says Buy These 3 Stocks for a Double-Digit Rally - Aug 14th, 2024 3:46 pm
Dow Jones Futures Fuel New Market Rally On Bank Of Japan; Nvidia Partner Super Micro Dives - Aug 7th, 2024 12:17 pm
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q2 Loss, Tops Revenue Estimates - Jul 30th, 2024 12:40 pm
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress - Jul 30th, 2024 11:30 am
Day One Announces Oversubscribed $175.0 Million Private Placement - Jul 30th, 2024 11:00 am
Ipsen outlines $461m for ex-US rights to Day One’s glioma therapy - Jul 25th, 2024 3:53 pm
Lupita Nyong’o Shimmers in Sequined Off-the-shoulder Prada Jumpsuit and Satin Miniskirt at ‘A Quiet Place: Day One’ Premiere - Jun 27th, 2024 1:51 pm
Lupita Nyong’o Gives Power Suiting a Sensual Spin in Double-breasted Blazer and High-waisted Shorts for ‘A Quiet Place: Day One’ Photo Call - Jun 24th, 2024 8:50 pm
Insider Selling: Director Saira Ramasastry Sells Shares of Day One Biopharmaceuticals Inc (DAWN) - Jun 22nd, 2024 8:11 am
Day One targets the growing ADC market with MabCare acquisition - Jun 19th, 2024 4:14 pm
Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers - Jun 18th, 2024 12:30 pm
Exclusive: Day One Ventures closes its third fund at $150 million - Jun 11th, 2024 11:46 am
Day One Announces Sale of Priority Review Voucher for $108 Million - May 30th, 2024 12:30 pm
Day One Reports First Quarter 2024 Financial Results and Corporate Progress - May 6th, 2024 8:30 pm
Insider Sale at Day One Biopharmaceuticals Inc (DAWN) - May 4th, 2024 6:31 am
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor - Apr 23rd, 2024 7:56 pm